The epidermal growth factor receptor as a target for cancer therapy.
about
Survival of cancer cells is maintained by EGFR independent of its kinase activityTargeting the insulin growth factor receptor 1EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabResistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?The direct interaction of phospholipase C-gamma 1 with phospholipase D2 is important for epidermal growth factor signalingGrowth factor engineering by degenerate homoduplex gene family recombination.Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Chronopharmacology and mechanism of antitumor effect of erlotinib in Lewis tumor-bearing miceEmerging therapies in gastrointestinal cancers.Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.Targeting the EGFR signaling pathway in cancer therapy.A pilot characterization of human lung NSCLC by protein pathway activation mapping.Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.Anti-epidermal growth factor receptor drugs in cancer therapy.Novel treatments and therapies in development for pancreatic cancer.Construction of a novel constitutively active chimeric EGFR to identify new targets for therapyInduction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4Role of targeted therapy in non-small cell lung cancer: hype or hope?Extracellular molecules involved in cancer cell invasionTyrosine kinase inhibitors as cancer therapy.Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials.Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung CancerPlakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFREnhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Molecular-targeted agents in pancreatic cancer.Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancerAberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cellsRadiotherapy and erlotinib combined: review of the preclinical and clinical evidenceThe Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance.Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude miceEpidermal growth factor receptor inhibitors in cancer treatment.Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells.Cellular immunotherapy for carcinoma using genetically modified EGFR-specific T lymphocytes.Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer.Receptor signaling as a regulatory mechanism of DNA repair.Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.
P2860
Q24309274-0250E998-7DCB-4E2F-8564-4344F23D1D14Q24633750-A0062F03-8DFD-496E-A301-C32916F7F1AFQ24652337-64E84553-3B64-4AA1-A987-0171074D2654Q26739760-F13F0DC5-AB0B-4F77-9784-22754AA3FAE0Q28184932-A9C35E01-8A63-453C-86D1-DC394BDB681AQ30869925-D0558447-4048-4A62-BB7B-5816B38F2BC0Q33358967-78A86AB4-1D69-4AEA-AD89-B2B28D8F8020Q33684453-4C135EAE-FF24-44DD-9FA2-54ADE0107CC3Q33856506-ECF43587-A8AF-4A8A-AE18-49052B117720Q33866870-6B07FFA6-82BE-48AC-A505-AE0D3D66A125Q34067821-E1204382-249D-45AF-8E9D-0E97D79A6715Q34246558-98282903-8ACA-4E44-BCD3-0654EB026871Q34478770-58EF2BE4-8F84-46F8-9F38-7AE245900125Q34504860-07465E45-5A55-4C1E-8EF8-23DD2AAE9C56Q34589774-0C21A3BC-C022-4BA3-8BF5-569F9B96B2DBQ34660837-5A2581F7-8652-4D99-A4B8-F9980730F5CEQ34660844-81B676C4-062A-4E77-9A5B-2F688589A1C4Q34768516-A104D73B-657E-4FB0-97D0-3F76E054B3EFQ34768930-B53E6AE7-594E-4D61-9535-C640936C5584Q35157356-9034DCF8-AC9F-430D-9AD9-46CD5B7CB456Q35204943-B4AD84E3-B613-44AF-B28F-CE6227E1B0B2Q35237503-3B02C14F-D588-4F2C-8CF3-43207E0B2DBBQ35589206-8ECCDEDF-1BF6-4B8D-9B97-4100A48A7C6CQ35602676-FB2877E9-AE56-49E4-B94F-0ED6F0C86E8BQ35608002-423D1172-C07F-44DC-A012-344FF777D9A7Q35618896-293BE2C8-C1B1-479D-A4B6-F3B8C5F09734Q35624010-F8F583AC-C354-4AF9-B943-4E4CEE38CA67Q35641998-22F268C8-56D0-46A3-8651-7F5BF3C6DD0DQ35741633-5CF77BE3-E88E-4A7A-995E-8FCE204CBD7EQ35749110-6FBD5E29-CE0D-4EE8-A6BC-4BAB55A3B0B1Q35970960-E8676C96-4E11-4D57-8A33-6ADB6E569975Q36141361-4302BD2F-2D2D-4C2A-99C9-847E3E0CC729Q36246406-65880D54-2ED4-4549-AECA-B9246B4657AFQ36259629-A8D28943-5F5D-4504-975C-BA43CAE94D91Q36429442-48FDE5D0-E942-4FB9-9F84-A679C16FBBD6Q36626059-B0B3DF82-2648-4708-AAF6-17CD8BAA9B0AQ36801106-7213A1B2-4FE0-4E17-BDBD-22FB7816599DQ36832116-05230D2C-249C-4D13-A89C-9BF493BA1335Q37368256-07931C82-EA50-4970-9B3C-B1478298FA59Q37395986-785EABDC-1ED9-443B-8AAD-99D86F1B4784
P2860
The epidermal growth factor receptor as a target for cancer therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The epidermal growth factor receptor as a target for cancer therapy.
@ast
The epidermal growth factor receptor as a target for cancer therapy.
@en
The epidermal growth factor receptor as a target for cancer therapy.
@nl
type
label
The epidermal growth factor receptor as a target for cancer therapy.
@ast
The epidermal growth factor receptor as a target for cancer therapy.
@en
The epidermal growth factor receptor as a target for cancer therapy.
@nl
prefLabel
The epidermal growth factor receptor as a target for cancer therapy.
@ast
The epidermal growth factor receptor as a target for cancer therapy.
@en
The epidermal growth factor receptor as a target for cancer therapy.
@nl
P356
P1476
The epidermal growth factor receptor as a target for cancer therapy.
@en
P2093
Mendelsohn J
P356
10.1677/ERC.0.0080003
P577
2001-03-01T00:00:00Z